Thedoctorschannel Domain Overviewđź”’ SSL Verified
Live Data Status: |E-commerce & Retail
Welcome to the detailed analysis for thedoctorschannel.com. This domain is officially recognized as The Doctor's Channel – Free Medical News – Short Video for Docs. According to their official web presence, their primary focus is: "Detailed SEO and authority metrics for thedoctorschannel.com. Thedoctorschannel currently holds an estimated domain authority score of 61/100 in the .COM namespace based on our global index mapping.".
Table of Contents
- ↓ Using Virtual Reality to Improve Patient Education: Evidence from the CyberCell™ Program
- ↓ EMBER-2 Results
- ↓ New Strategies for TP53-Mutated AML
- ↓ Trending on The Doctor's Channel
- ↓ Non-Small Cell Lung Cancer – Yale Medicine Explains
- ↓ FLT3 Inhibitors for Managing Patients With AML
- ↓ Top Alternatives to thedoctorschannel.com
- Tech Stack
- WordPress
- Link Profile
- Internal Pages: 66Outbound Links: 1
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$4,197
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- thedoctorschannel.comTaken
- thedoctorschannel.netTaken
- thedoctorschannel.orgTaken
- thedoctorschannel.ioTaken
- thedoctorschannel.coTaken
- thedoctorschannel.aiAvailable
Content Snippets from thedoctorschannel.com
"Patrick Neven, MD, Universitair Ziekenhuis Leuven, Leuven, Belgium, presents data from the EMBER-2 window-of-opportunity study, in which imlunestrant was given for about 2 weeks before surgery in women…"
"In this panel discussion from the 7th International Workshop on Acute Leukemias, Eunice Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY; Andrew Wei, MBBS, PhD, Peter MacCallum…"
"Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…"
"Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, reviews the role of FLT3 inhibitors for treating patients with FLT3-mutated acute myeloid leukemia. Dr Perl discusses how FLT3 inhibitors…"
Key Topics & Focus Areas for thedoctorschannel.com:
Using Virtual Reality to Improve Patient Education: Evidence from the CyberCell™ Program
EMBER-2 Results
New Strategies for TP53-Mutated AML
Trending on The Doctor's Channel
Non-Small Cell Lung Cancer – Yale Medicine Explains
FLT3 Inhibitors for Managing Patients With AML
By comparing thedoctorschannel.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to thedoctorschannel.com.
Frequently Asked Questions
Is thedoctorschannel.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of thedoctorschannel.com?
As of July 24, 2026, thedoctorschannel.com holds an estimated domain authority score of 66/100 based on our VisitRank tracking algorithms.
What are the top alternatives to thedoctorschannel.com?
You can find the best alternatives and similar sites to thedoctorschannel.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for thedoctorschannel.com:
tehdoctorschannel.comthdoctorschannel.comthhedoctorschannel.comthadoctorschannel.comthedoctorschannel.comthedoctorschennel.comthedoctorschannal.comtgedoctorschannel.comtyedoctorschannel.com